Evidence map›Paper›PMID 30211610›Full record

ArticleNeuropsychology2018

Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.

Ariana E Anderson, Jacob D Jones, Nicholas S Thaler, Taylor P Kuhn, Elyse J Singer, Charles H Hinkin

Abstract read
In one paragraph

Article in Neuropsychology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Examining the Stability and Predictive Utility of Across- and Within-Domain Intra-Individual Variability in Mild Cognitive Impairment.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Digital Neuropsychology beyond Computerized Cognitive Assessment: Applications of Novel Digital Technologies.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ariana E AndersonDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Geffen School of Medicine.ORCID 0000-0003-2207-5284
Jacob D JonesDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Geffen School of Medicine.ORCID 0000-0003-3544-7294
Nicholas S ThalerDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Geffen School of Medicine.
Taylor P KuhnDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Geffen School of Medicine.
Elyse J SingerDepartment of Neurology, University of California, Los Angeles.
Charles H HinkinDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Geffen School of Medicine.

Funding

The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
NEUROSPYCHOLOGY AIDS FELLOWSHIPT32MH019535 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HINKIN, CHARLES H · 1991 to 2017
$2.3M
Hemodynamic Biomarkers of Healthy and Diseased AgingK25AG051782 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANDERSON, ARIANA · 2016 to 2020
$667k
Modeling RDoc Dimensions Across Levels of AnalysisR03MH106922 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANDERSON, ARIANA · 2016 to 2017
$154k
NIA NIH HHS K25 AG051782NIMH NIH HHS R03 MH106922NIMH NIH HHS T32 MH019535NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

objectiveHIV-associated neurocognitive disorder (HAND) occurs in a significant percentage of HIV-infected (HIV+) adults. Increased intraindividual variability (IIV) in cognitive function may be an early marker of emerging neurocognitive disorder, which suggests that IIV may be a sensitive measure of neurologic compromise in HIV. In the current study, we hypothesize that increased IIV may predict impending morbidity, including future cognitive decline and death.

methodIn 708 HIV+ participants followed longitudinally for up to 14 years, we assessed the role of dispersion in forecasting death and cognitive decline. Incident neurocognitive impairment was predicted in a mixed-effects ordinal logistic regression model using age, gender, baseline mean cognitive functioning, CD4+, time followed, years of education, and dispersion at the previous visit. Death before the next visit was predicted in a binomial mixed-effects regression model using age, gender, baseline mean cognitive functioning, CD4+, time followed, years of education, and dispersion.

resultsPoint-in-time dispersion and change in dispersion between visits predict future cognitive decline and death in HIV+ individuals. Individuals with greater dispersion at a visit or who had larger changes in dispersion between visits were more likely to demonstrate greater neurocognitive impairment at the subsequent visit. Greater IIV was also associated with an increased risk of death prior to the subsequent visit, even after controlling for HAND severity and global cognitive functioning.

conclusionsWe conclude that the IIV in cognitive functioning may be more predictive of future disease consequence than mean level of cognitive functioning. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Indexed as

AdultAgedAged, 80 and overAge FactorsAIDS Dementia ComplexCD4 Lymphocyte CountCognitive DysfunctionDisease ProgressionEducational StatusFemaleHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedNeuropsychological Tests

Identifiers

PMID30211610
PMCPMC6234088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.